ATR
ATR (ATR checkpoint kinase, previously ataxia telangiectasia and Rad3 related) is a serine/threonine protein kinase that senses DNA damage and replication stress and activates checkpoint signalling. It is also known as FRP1, SCKL, SCKL1 and MEC1. Browse Assay Genie's current range of ATR research reagents below, or read on for the biology behind the target.
ATR is a serine/threonine kinase that activates checkpoint signalling in response to genotoxic stresses such as ionising radiation, ultraviolet light and stalled DNA replication, so acting as a DNA damage sensor. It recognises the substrate consensus sequence [ST]-Q and phosphorylates BRCA1, CHEK1, MCM2, RAD17, RBBP8, RPA2, SMC1 and p53/TP53. Together these events inhibit DNA replication and mitosis and promote DNA repair, recombination and apoptosis. ATR also phosphorylates Ser-139 of histone variant H2AX at sites of damage, and is required for FANCD2 ubiquitination.
Beyond the classical checkpoint, ATR restricts CDK1 activity during S-phase to prevent premature entry into G2, and helps maintain fragile site stability and efficient centrosome duplication. It positively regulates restart of stalled replication forks following activation by the KHDC3L-OOEP scaffold complex. At the nuclear envelope, ATR acts as a mechanical stress sensor: it relocalises there under mechanical stress and mediates a checkpoint through CHEK1 phosphorylation. It can also promote nuclear envelope rupture after DNA damage by phosphorylating LMNA at Ser-282, leading to lamin disassembly.
ATR is also involved in the inflammatory response to genome instability. It localises to micronuclei and phosphorylates LMNA at Ser-395, priming it for CDK1 phosphorylation and micronuclear envelope rupture, which triggers the cGAS-STING pathway and a type I interferon response. The ATR gene belongs to the PI3/PI4-kinase family, ATM subfamily, and to the phosphatidylinositol 3-kinase-related kinase group. Defects in the gene cause Seckel syndrome 1. The mouse ortholog is Atr.
ATR senses genotoxic stress and phosphorylates H2AX, CHEK1 and p53/TP53 to coordinate checkpoint activation, repair and apoptosis.
ATR responds to stalled replication forks, supports their restart and limits CDK1 activity in S-phase to prevent premature G2 entry.
ATR relocalises to the nuclear envelope under mechanical stress and phosphorylates LMNA, linking genome stress to envelope integrity.
ATR activity at micronuclei leads to envelope rupture and cGAS-STING signalling, connecting DNA damage to type I interferon responses.
ATR is a serine/threonine kinase that senses DNA damage and replication stress. It phosphorylates substrates including CHEK1, p53/TP53, BRCA1 and H2AX to halt DNA replication and mitosis and promote repair, recombination and apoptosis. It also regulates the S-G2 transition and nuclear envelope integrity.
ATR stands for ATR checkpoint kinase and was previously named ataxia telangiectasia and Rad3 related. Aliases and earlier symbols include FRP1, SCKL, SCKL1 and MEC1. UniProt lists the protein as serine/threonine-protein kinase ATR, and the mouse ortholog is Atr.
Yes. According to the NCBI Gene summary, defects in the ATR gene are a cause of Seckel syndrome 1. ATR is also important for fragile site stability and centrosome duplication. Check the datasheet of any product for its validated reactivity.
Proteins with related names and DNA damage response targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13535; product specifications from Assay Genie datasheets.